Effects of cannabidiol on symptoms induced by the recall of traumatic events in patients with posttraumatic stress disorder (2022)
- Authors:
- USP affiliated authors: CRIPPA, JOSÉ ALEXANDRE DE SOUZA - FMRP ; HALLAK, JAIME EDUARDO CECILIO - FMRP ; GUIMARÃES, FRANCISCO SILVEIRA - FMRP ; ZUARDI, ANTONIO WALDO - FMRP
- Unidade: FMRP
- DOI: 10.1007/s00213-021-06043-y
- Subjects: ANSIEDADE; FARMACOTERAPIA; CANABINOIDES; TRANSTORNOS DA ANSIEDADE; TRANSTORNO DO STRESS PÓS-TRAUMÁTICO
- Keywords: Posttraumatic stress disorder; Aversive memories; Memory reconsolidation; Cannabidiol
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: Heidelberg
- Date published: 2022
- Source:
- Título do periódico: Psychopharmacology
- ISSN: 0033-3158
- Volume/Número/Paginação/Ano: v. 239, n. 5, p. 1499-1507, 2022
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
BOLSONI, Lívia Maria et al. Effects of cannabidiol on symptoms induced by the recall of traumatic events in patients with posttraumatic stress disorder. Psychopharmacology, v. 239, n. 5, p. 1499-1507, 2022Tradução . . Disponível em: https://doi.org/10.1007/s00213-021-06043-y. Acesso em: 14 maio 2024. -
APA
Bolsoni, L. M., Crippa, J. A. de S., Hallak, J. E. C., Guimarães, F. S., & Zuardi, A. W. (2022). Effects of cannabidiol on symptoms induced by the recall of traumatic events in patients with posttraumatic stress disorder. Psychopharmacology, 239( 5), 1499-1507. doi:10.1007/s00213-021-06043-y -
NLM
Bolsoni LM, Crippa JA de S, Hallak JEC, Guimarães FS, Zuardi AW. Effects of cannabidiol on symptoms induced by the recall of traumatic events in patients with posttraumatic stress disorder [Internet]. Psychopharmacology. 2022 ; 239( 5): 1499-1507.[citado 2024 maio 14 ] Available from: https://doi.org/10.1007/s00213-021-06043-y -
Vancouver
Bolsoni LM, Crippa JA de S, Hallak JEC, Guimarães FS, Zuardi AW. Effects of cannabidiol on symptoms induced by the recall of traumatic events in patients with posttraumatic stress disorder [Internet]. Psychopharmacology. 2022 ; 239( 5): 1499-1507.[citado 2024 maio 14 ] Available from: https://doi.org/10.1007/s00213-021-06043-y - Effects of minocycline on regional cerebral blood flow in schizophrenia
- Canabidiol: possíveis aplicacões terapêuticas em psicopatologias
- A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation
- Possible therapeutic uses of cannabidiol in anxiety disorders and schizophrenia
- Cannabidiol, a cannabis sativa constituent, as an antipsycholic drug
- Is the highest density of CB1 receptors in paranoid schizophrenia a correlate of endocannabinoid system functioning?
- Cannabidiol: an anxiolytic or an antipsychotic new drug?
- Glutamate-N-methyl-D-aspartate receptor modulation and minocycline for the treatment of patients with schizopherenia: an update
- Cannabidiol for the treatment of crack-cocaine craving: an exploratory double-blind study
- Acute harmine administration induces antidepressive-like effects and increases BDNF levels in the rat hippocampus
Informações sobre o DOI: 10.1007/s00213-021-06043-y (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
